In this study we show that inhibition of NF-κB using the small peptide inhibitor NBD improves contractile force, improves the force-frequency relationship, and restores the response to β-adrenergic stimulation in the well-established murine model for cardiac dysfunction associated with DMD. Here, NFKB1 is linked to Duchenne muscular dystrophy.